Pregled bibliografske jedinice broj: 219484
Our Experiences in the Treatment of Supraventricular Paroxismal Tachycardia
Our Experiences in the Treatment of Supraventricular Paroxismal Tachycardia // 4WCPCCS, Abstract book
Buenos Aires, 2005. (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 219484 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Our Experiences in the Treatment of Supraventricular Paroxismal Tachycardia
Autori
Mustapić, Željka ; Malčić, Ivan ; Dasović-Buljević, Andrea ; Kniewald, Hrvoje ; Šarić, Dalibor ; Rojnić-Putarek, Nataša
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
4WCPCCS, Abstract book
/ - Buenos Aires, 2005
Skup
4th world congress of pediatric cardiology and cardiac surgery
Mjesto i datum
Buenos Aires, Argentina, 18.09.2005. - 22.09.2005
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Supraventricular paroxismal tachycardia; therapy
Sažetak
Introduction: we present our experiences in menagement of supraventricular paroxismal tachycardia (PSVT) in children without congenital heart disease Methods: Retrospective review of 33 out-hospital patients (mean age 7 years, 3 younger than 1 year) followed a mean of 14 months. From January 2000 to January 2005, 16 (48%) girls and 17 (52%) boys presented with PSVT. Nineteen (57.6%) patients have PSVT by surface ECG criteria and the rest were diagnosed by anamestic data. In one girl SVPT was diagnosed prenataly at the gestational age of 27th weeks and converted with medigoxine taken by mother. After the age of 4 months she had no therapy and no PSVT episodes. Preexcitation syndroms was found in 8 (25%) patients. Thirteen patients terminate acute episodes of PSVT by using vagal maneuvers (40.6%), 19 had chronic drug therapy (59.4%). Sotalol were taking 16 of them (84.2%), and 2 patients medigoxine. We succesfuly ended profilactic therapy with propafenone in one child at the age of 1 year with no recurrence of SVPT. Two girls underwent catheter ablation due to poor response to drug therapy. All patients younger than 1 year presented with heart failure. Leading symptoms in older patients were palpitations and chest pain. Prolonged episodes of SVPT were terminated with intravenous application of adenosine. Conclusion: Most patients with SVPT can be managed with physiological maneuvers (40.6%), with no ablation. Adenosine is a drug of choice for terminating SVPT and digoxine for the termination of intrauterine SVPT.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
0108173
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Ivan Malčić
(autor)
Andrea Dasović Buljević
(autor)
Nataša Rojnić Putarek
(autor)
Željka Mustapić
(autor)